DATABASE CATEGORY-REGISTRY
DRUG
CLASSES
PHARMACEUTICAL DATABASE

Drug Categories

Pharmacological categories of ADHD medications.

5 Total Categories
2 Stimulants
3 Non-Stimulants

Stimulants

2 categories

First-line treatment for ADHD. Work by increasing dopamine and norepinephrine in the brain. Fast-acting but are controlled substances.

Learn more on Wikipedia
methylphenidate 1 drugs

Methylphenidate

Methylphenidate is a central nervous system stimulant that works by blocking the reuptake of dopamine and norepinephrine. It is the most widely prescribed ADHD medication globally, available in immediate-release and extended-release formulations.

Mechanism Dopamine-norepinephrine reuptake inhibitor (DNRI)
Common Brands
RitalinConcertaDaytrana
amphetamine 2 drugs

Amphetamine

Amphetamines are potent central nervous system stimulants that increase the release and block the reuptake of dopamine and norepinephrine. They include mixed amphetamine salts (Adderall) and the prodrug lisdexamfetamine (Vyvanse). More restricted globally than methylphenidate.

Mechanism Dopamine-norepinephrine releasing agent (DNRA)
Common Brands
AdderallVyvanseDexedrine
Prohibited or highly restricted in many Asian countries including China and Japan

Non-Stimulants

3 categories

Alternative treatments when stimulants are ineffective, contraindicated, or cause intolerable side effects. Generally not controlled substances, making them easier to prescribe and travel with.

Learn more on Wikipedia
atomoxetine 0 drugs

Atomoxetine

Atomoxetine is a selective norepinephrine reuptake inhibitor (SNRI) and the first non-stimulant medication approved for ADHD. It is not a controlled substance in most countries, making it easier to prescribe and travel with. Takes 4-6 weeks for full effect.

Mechanism Selective norepinephrine reuptake inhibitor (SNRI)
Common Brands
Strattera
alpha2-agonist 0 drugs

Alpha-2 Agonists

Alpha-2 adrenergic agonists (guanfacine, clonidine) were originally developed for hypertension but are now approved for ADHD. They work by stimulating alpha-2 receptors in the prefrontal cortex, improving attention and impulse control without stimulant effects.

Mechanism Alpha-2 adrenergic receptor agonist
Common Brands
Intuniv (guanfacine)Kapvay (clonidine)
viloxazine 0 drugs

Viloxazine

Viloxazine is a newer non-stimulant ADHD medication approved by the FDA in 2021. It is a selective norepinephrine reuptake inhibitor with serotonin modulating activity. Originally used as an antidepressant in Europe, it was reformulated for ADHD treatment.

Mechanism Selective norepinephrine reuptake inhibitor with serotonin modulating activity
Common Brands
Qelbree